MULTIROS glatiramer acetate 20 mg/1mL solution for injection prefilled syringe

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

glatiramer acetate, Quantity: 20 mg/mL

Disponible depuis:

Juno Pharmaceuticals Pty Ltd

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: mannitol; water for injections

Mode d'administration:

Subcutaneous

Unités en paquet:

28

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Reduction of the frequency of relapses in patients with Relapsing Remitting Multiple Sclerosis.,Treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent MRI lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.

Descriptif du produit:

Visual Identification: Clear solution in a clear, colourless glass syringe equipped with needle covered by a needle shield, stopper and piston rod.; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Registered

Date de l'autorisation:

2020-11-12